Regulus Therapeutics Inc (NASDAQ:RGLS)

0.6534
Delayed Data
As of Apr 20
 -0.0062 / -0.94%
Today’s Change
0.63
Today|||52-Week Range
1.95
-37.17%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Papadopoulos Stelios B
Director
Buy7/25/20171,000,000$0.91$910.0K-41.14%
Rastetter William H
Director
Buy7/25/2017274,725$0.91$250.0K-41.14%
Wright Timothy M
Buy7/25/2017274,725$0.91$250.0K-41.14%
Hagan Joseph P
President & Chief Executive Officer
Buy7/25/2017219,780$0.91$200.0K-41.14%
Papadopoulos Stelios B
Director
Gift12/04/201796,629$0.89$86.0K-26.59%
Foletta Mark G
Director
Gift12/04/201771,910$0.89$64.0K-26.59%
Rastetter William H
Director
Gift12/04/201769,662$0.89$62.0K-26.59%
Witz Pascale
Director
Gift12/04/201760,674$0.89$54.0K-26.59%
Baltimore David
Director
Gift12/04/201760,674$0.89$54.0K-26.59%
Chevallard Daniel R
Chief Financial Officer
Buy7/25/201754,945$0.91$50.0K-41.14%
Page of 2